Patients Undergoing Laparoscopic Nephrectomy Walk Out From Operating Room After Surgery (WOFOR-N1)

October 29, 2022 updated by: SanQing Jin, Sixth Affiliated Hospital, Sun Yat-sen University

Effects of Walking Out From Operating Room on Postoperative Recovery of Patients Undergoing Laparoscopic Total or Partial Nephrectomy

Early mobilization is considered as an important strategy to enhance postoperative recovery. However, direct association between very early mobilization and improved recovery needs randomized control trials to prove. This study proposes the program of walking out from operating room (WOFOR) after surgery, which means that encouraging patients to walk out from the operating room and return to the ward by walking under the condition of painlessness, clear consciousness and normal muscle strength of lower limb. The aim of this randomized controlled trial is to investigate the effect of WOFOR on the postoperative recovery of patients undergoing laparoscopic total and partial nephrectomy.

Study Overview

Detailed Description

Postoperative bed rest increases the risk of complications such as thromboembolism and intestinal adhesion. Encouraging early mobilization after surgery should be important, although actual effects of early mobilization still need randomized control trails to prove. The aim of this randomized controlled trial is to investigate the effect of walking out from operating room (very early mobilization after surgery) on the postoperative recovery of patients undergoing laparoscopic total and partial nephrectomy.

A sample size of 91 patients in each group will be selected by a prior power analysis on the basis of the following assumptions: (1) an absolute reduction in the length of the hospital stay by 1 day, (2) standard deviation 2 days, (3) α=0.05, (4) power 90% and .(5) missed follow-up rate 5%.

Patients will receive written and verbal information about the trial before written consent is obtained. The randomization will take place before the day of the surgery and the patients will be assigned to either intervention (return to ward by walking) or control group (return to ward by lying on the transporting bed ). A stratified randomization with three factors including sex, disease character and age will be performed to ensure an even spread. The randomization is performed using concealed allocation where envelopes are prepared externally using a randomization list prepared by a statistician.

The patients will receive general anesthesia combined with epidural analgesia. After surgery, the patients will be evaluated whether fulfilling the criteria for mobilization including stable physiological parameters, consciousness, normal level of orientation and muscle strength, and painlessness every ten minutes. If patients fulfill the criteria, they will receive different methods of returning to the ward based on the grouping. In the control group, the patient will return to the ward by lying on the transporting bed. In the intervention group, the patients will be raised to a sitting position for five minutes. If the patients do not complain any discomfort and have stable physiological parameters, they will be encouraged to stand. If standing do not cause any discomfort, they will be encouraged to walk within the range of 5-meter long and 60-centimeter wide. If patients can walk within the range, they will return to the surgical ward by walking under the protection of medical staffs.

Then, all study patients will be subject to the same management such as the guidance of drink and diet recovery, the guidance of mobilization in the ward (the duration and distance of walking in the ward will be recorded every day), nutrition supplement after surgery, and the criteria of drainage removal and hospital discharge. The outcomes such as the length of hospital stay after surgery will be recorded and analyzed to evaluate the effects of walking out from the operating room. The analysis of Intention-to-treat and Per-protocol-sets will be both performed by statisticians.

Study Type

Interventional

Enrollment (Anticipated)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • GuangZhou, Guangdong, China, 510655
        • Recruiting
        • The Sixth Affiliated Hospital,Sun Yat-Sen University
        • Contact:
      • Guangzhou, Guangdong, China, 510655
        • Recruiting
        • The Sixth Affiliated Hospital, Sun Yat-Sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 18-65 Years old
  2. scheduled for laparoscopic partial nephrectomy or laparoscopic total nephrectomy.
  3. ASA grade I or grade II

Exclusion Criteria:

  1. Patients have severe cardiac diseases (cardiac function grading greater than grade 3/arrhythmia including sick sinus syndrome, atrial fibrillation, atrial flutter, atrioventricular block, frequent ventricular premature, multiple ventricular premature, ventricular premature R on T, ventricular fibrillation and ventricular flutter/acute coronary syndrome) or respiratory failure or hepatic failure or renal failure;
  2. body mass index (BMI) ≥30 kg/m2
  3. Patients have diabetics or patients with gastric emptying disorders;
  4. Patients with poor blood pressure control (receive regular antihypertensive medical treatment but still have systolic blood pressure > 150 mmHg and/or diastolic blood pressure > 90 mmHg );
  5. Patients have schizophrenia, epilepsy, Parkinson's disease, mental retardation, or hearing impairment.
  6. Patients have thrombosis such as in lower extremity or in vena cava or in renal vein or in other veins.
  7. Patients have neuromuscular disorders affecting lower limb activity, such as myasthenia gravis and cerebral infarction, which cause lower limb muscle weakness;
  8. Patients have contraindications for epidural puncture.
  9. Patients participate in other clinical trials.
  10. Patients refuse to sign informed consent for research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: walk out from operating room
patients will return to the ward after surgery by walking
After the surgery of laparoscopic total or partial nephrectomy, patients will be encouraged to walk out from the operating room and return to the ward by walking under the condition of stable physiological parameters, painlessness, clear consciousness and normal muscle strength of lower limb
NO_INTERVENTION: leave operating room by transporting bed
patients will return to the ward after surgery by lying on the transporting bed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay after surgery
Time Frame: at hospital discharge(expected 6 days after surgery)
hospital stay time from operation completion to actual hospital discharge,
at hospital discharge(expected 6 days after surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to fufill the criteria of hospital discharge (recovery time)
Time Frame: expected 6 days after surgery
The ideal time point for discharge, which is also considered as recovery time. The criteria for measuring recovery time included: 1) tolerance of diet and not necessary for intravenous nutrition; 2) analgesic-free, which is defined as visual analogue scale ≤3 without intravenous analgesic drugs, 3) adequate mobility; 4) afebrile status without major infectious complications
expected 6 days after surgery
The percentage of patients feeling ready for hospital discharge when they reach the discharge criteria.
Time Frame: expected 6 days after surgery
The percentage of patients feeling ready for hospital discharge when they reach the discharge criteria.
expected 6 days after surgery
Re-admission incidence within 30 days after operation
Time Frame: 30 days after operation
Incidence of admit to hospital again within 30 days after operation
30 days after operation
Postoperative recovery score using 40-item quality of recovery scoring system(QoR-40)
Time Frame: at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery)
To evaluate the postoperative recovery using 40-item quality of recovery scoring system including emotional state (9 items), physical comfort (12 items), physical independence (5 items), psychologic support (7 items), and pain (7 items). Each item is graded on a five-point Likert scale, and global scores range from 40 (extremely poor quality of recovery) to 200 (high quality of recovery).
at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery)
Six-minute walking test
Time Frame: the day before surgery, and at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery
Physical capacity measured with the six-minute Walking test before surgery and after surgery.The longer walking distance in six minutes, the better physical capacity.
the day before surgery, and at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery
Anxiety score
Time Frame: the day before surgery, and at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery
Anxiety state evaluated by State-Trait Anxiety Inventory Form. The form used in this study is the Chinese version. The scales consist of 20 items; the responses range from 1 to 4 points (forced choice). The scores range from 20 (extremely low level of anxiety) to 80 (high level of anxiety). The STAI classifies anxiety into five stages: stages 1 and 2 suggest mild anxiety; stage 3 suggests moderate anxiety, and stages 4 and 5 suggest severe anxiety.
the day before surgery, and at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery
Postoperative pain score
Time Frame: at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery)
Pain score after surgery is evaluated using a visual analogue scale 0-10 rated by the patients
at 1-day, 2-day, 3-day, 4-day after surgery(up to 4 days after surgery)
Severity of postoperative nausea and vomiting
Time Frame: at 1-day, 2-day after surgery(up to 2 days after surgery)
Severity of postoperative nausea and vomiting is measured with the PONV intensity scale. Briefly, no PONV is defined as the absence of any emetic symptoms and nausea during the entire study period. Mild PONV is defined as the occurrence of mild nausea or one episode of vomiting if caused by an exogenous stimulus such as drinking or movement. Moderate PONV is reached when the patient vomits up to 2 times or experiences nausea that requires a rescue antiemetic therapy only once. Severe PONV is reached if the patient suffers more than two emetic episodes or needs more than one dose of a rescue antiemetic drugs.
at 1-day, 2-day after surgery(up to 2 days after surgery)
Time to first flatus after surgery
Time Frame: at the time of first exhaust after surgery(expected average of 2 days after surgery)
the time length between operation completion and the first flatus
at the time of first exhaust after surgery(expected average of 2 days after surgery)
Time to first defecation after surgery
Time Frame: at the time of the first defecation after surgery(expected average of 3 days after surgery)
the time length between operation completion and the first defecation
at the time of the first defecation after surgery(expected average of 3 days after surgery)
The volume of drainage after surgery
Time Frame: expected average of 4 days after surgery
Total volume of drainage after surgery and drainage volume at 24-hour and 48-hour after the end of surgery.
expected average of 4 days after surgery
Time to the removal of drainage tube
Time Frame: at the time of drainage removal(expected average of 4 days after surgery)
recorded the time length between operation completion and the removal of drainage tube
at the time of drainage removal(expected average of 4 days after surgery)
Incidence of surgical complications within 30 days after surgery
Time Frame: 30 days after surgery
Incidence of bleeding, wound infection, wound dehiscence within 30 days after surgery
30 days after surgery
Incidence of major cardiovascular and cerebrovascular adverse events within 30 days after operation
Time Frame: 30 days after surgery
Incidence of a complex event consisting of all-cause death, myocardial infarction, stroke and emergency target vessel revascularization within 30 days after surgery
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 4, 2019

Primary Completion (ANTICIPATED)

August 1, 2023

Study Completion (ANTICIPATED)

August 1, 2023

Study Registration Dates

First Submitted

May 16, 2019

First Submitted That Met QC Criteria

May 20, 2019

First Posted (ACTUAL)

May 23, 2019

Study Record Updates

Last Update Posted (ACTUAL)

November 1, 2022

Last Update Submitted That Met QC Criteria

October 29, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • SixthSunYatSen

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Enhanced Recovery After Surgery

Clinical Trials on walk out from operating room

3
Subscribe